Statistics

Total Visits

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study99

Select a period of time:

Number of views in the range

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study25

Views

Views
September 202510
October 20254
November 20255
December 20254
January 20261
February 20260
March 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
Brazil5
United Kingdom4
Colombia1
Panama1
Puerto Rico1
Uruguay1
South Africa1
 

Top cities views

Views
Dallas4
Ashburn1
Bogotá1
Campina Grande1
Canovanas1
Johannesburg1
Montevideo1
Oriximiná Municipality1
Panama City1
Porto Alegre1